BVF as of Sept. 30, 2017
Portfolio Holdings for BVF
BVF holds 37 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Array BioPharma | 10.0 | $79M | 6.4M | 12.30 | |
Blueprint Medicines (BPMC) | 8.9 | $70M | 1.0M | 69.67 | |
Chemocentryx | 7.2 | $56M | 7.6M | 7.42 | |
Anaptysbio Inc Common (ANAB) | 6.1 | $48M | 1.4M | 34.95 | |
Concert Pharmaceuticals I equity | 5.9 | $46M | 3.1M | 14.75 | |
Glycomimetics (GLYC) | 5.7 | $45M | 3.2M | 13.99 | |
Ironwood Pharmaceuticals (IRWD) | 5.7 | $45M | 2.8M | 15.77 | |
Cytomx Therapeutics (CTMX) | 5.2 | $41M | 2.2M | 18.17 | |
Xoma Corp Del (XOMA) | 3.8 | $30M | 1.5M | 19.65 | |
Biolinerx Ltd-spons | 3.7 | $29M | 26M | 1.12 | |
Cti Biopharma | 3.5 | $27M | 8.6M | 3.19 | |
Loxo Oncology | 2.8 | $22M | 238k | 92.12 | |
Kura Oncology (KURA) | 2.6 | $20M | 1.4M | 14.95 | |
Oncomed Pharmaceuticals | 2.5 | $20M | 4.4M | 4.52 | |
Zealand Pharma A/s- | 2.4 | $19M | 1.0M | 19.20 | |
Cytokinetics (CYTK) | 2.3 | $18M | 1.2M | 14.50 | |
Pieris Pharmaceuticals (PIRS) | 2.2 | $17M | 3.0M | 5.76 | |
Regulus Therapeutics | 2.1 | $16M | 13M | 1.25 | |
Intra Cellular Therapies (ITCI) | 1.9 | $15M | 950k | 15.78 | |
Tocagen | 1.7 | $13M | 1.1M | 12.46 | |
Cascadian Therapeutics | 1.6 | $13M | 3.1M | 4.09 | |
Spring Bk Pharmaceuticals In | 1.4 | $11M | 653k | 16.84 | |
Xenon Pharmaceuticals (XENE) | 1.4 | $11M | 3.6M | 2.95 | |
Infinity Pharmaceuticals (INFIQ) | 1.3 | $11M | 7.9M | 1.33 | |
Gtx Inc Del | 1.2 | $9.1M | 1.1M | 8.22 | |
Forward Pharma A/s | 1.1 | $8.6M | 1.5M | 5.89 | |
ArQule | 1.0 | $8.2M | 7.4M | 1.11 | |
Alpine Immune Sciences (ALPN) | 1.0 | $7.8M | 676k | 11.60 | |
Corvus Pharmaceuticals (CRVS) | 0.9 | $7.3M | 459k | 15.94 | |
Molecular Templates | 0.6 | $5.0M | 724k | 6.97 | |
Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.6 | $4.8M | 10M | 0.48 | |
Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.0M | 2.0M | 1.94 | |
Contrafect | 0.5 | $3.9M | 3.5M | 1.11 | |
Aduro Biotech | 0.2 | $2.0M | 185k | 10.65 | |
Orexigen Therapeutics | 0.2 | $1.6M | 735k | 2.12 | |
Anthera Pharmaceuticals (ANTH) | 0.2 | $1.4M | 1.0M | 1.44 | |
Pain Therapeutics | 0.2 | $1.3M | 326k | 4.07 |